Accrual to Clinical Trials (ACT)

This service is provided by the Biomedical Informatics Resource and the Trial Innovation Network Hub Liaison Team.

Overview

The Accrual to Clinical Trials (ACT) Network is a real-time platform allowing researchers to explore and validate feasibility for clinical studies across the NCATS Clinical and Translational Science Award (CTSA) consortium, from their desktops. ACT helps researchers plan and complete clinical studies, and is IRB-approved. To access the ACT platform, researchers at Columbia University must contact our Clinical Data Navigator. 

ACT was developed collaboratively by members of NCATS’ Clinical and Translational Science Award (CTSA) consortium, with funding from the NIH National Center for Advancing Translational Sciences.

Eligibility

This service is available to all researchers and clinical trialists at Columbia University.

When to Request This Service

This service should be requested at least two months prior to any grant or protocol submission deadlines.

Cost

There is no cost for this service.

Cite it, Submit it, Share it!

If your research has benefited from one or more Irving Institute resources, please remember to:

  • Cite our CTSA grant, UL1 TR001873, in any relevant publications, abstracts, chapters, and/or posters.
  • Submit your publications to PubMed Central (PMC) for compliance with the NIH Public Access Policy.
  • Share your research updates with us by sending an email to: irving_institute@cumc.columbia.edu

Contact

Accrual to Clinical Trials
622 West 168th Street, 10th Floor
New York, NY 10032
United States